Über diese Senior/ Principal Manager Central Imaging* Stelle bei Immatics
OVERVIEW
We are currently seeking a Principal Manager Central Imaging* to strengthen our Clinical Sciences team in the clinical development of innovative cancer immunotherapeutic products. You will work in an interdisciplinary environment with internal colleagues and external imaging vendors and will contribute to our mission of delivering novel PRAME immunotherapies to patients with cancer.
The position can be filled in Tübingen, Munich or remote within Germany and is offered on a fixed-term contract for 24 months.
YOUR MISSION
You will independently manage central imaging activities for assigned global oncology trials and contribute scientific expertise to imaging endpoints and response assessments. Your main responsibilities will include but are not limited to the following tasks:
- Provide risk-based oversight of imaging vendors, monitoring image quality, query resolution, turnaround times, reader performance and adjudication metrics. Drive issue resolution and escalate risks impacting study milestones.
- Coordinate vendor and site readiness, including imaging systems, training, image submission processes, and review of imaging charters, manuals and project plans.
- Partner with Clinical Operations and vendors on site onboarding, imaging training and compliance with imaging procedures.
- Collaborate with Data Management and Biostatistics on imaging eCRFs, data specifications, reconciliation and transfers to ensure reliable endpoint data and timely analyses.
- Develop and implement central imaging strategies for assigned trials, aligning imaging endpoints, response criteria (e.g., RECIST 1.1, iRECIST) and operational requirements with study design.
- Provide imaging expertise for protocols, amendments, statistical analysis plans and regulatory documents, including radiation protection and patient-facing materials.
- Define imaging vendor requirements and support vendor qualification, selection and contracting in partnership with Vendor Management, Quality Assurance and Legal.
- Support imaging audits and inspections, maintain oversight of documentation and track corrective and preventive actions.
- Contribute to clinical study reports, regulatory submissions and publications, and develop imaging procedures, work instructions and training materials.
YOUR PROFILE
You hold an MSc, PharmD or preferably a PhD in Life Sciences, Medicine, Pharmacy or a related field and bring 4+ years of experience in clinical development, clinical trial management and central imaging in oncology. You have expertise in BICR processes, CT/MRI/PET imaging, RECIST 1.1 and iRECIST, as well as managing imaging vendors and operations in global clinical trials. Experience in late-stage oncology, immuno-oncology, T-cell therapies or T-cell-engaging bispecifics is highly desirable.
You possess strong knowledge of ICH-GCP and clinical imaging requirements and can assess imaging data and processes, identify risks and implement effective solutions. Experience with regulatory submissions, audits and inspections is a plus.
You are an independent, analytical and collaborative professional with excellent English communication skills (German is considered an advantage) who thrives in a dynamic environment. A structured, proactive mindset, strong ownership and a passion for improving outcomes for patients with cancer complete your profile.
WHY US?
We are the global leader in precision targeting of PRAME. Driven by our mission to make an impact on the lives of patients with cancer, we are a committed and inspired team and cherish the collegial, highly motivated, and family-friendly atmosphere within Immatics. We offer an innovative and collaborative environment where employees are empowered to contribute to groundbreaking cancer therapies and further their professional growth. To support their well-being, we provide opportunities for continuous learning, a company-sponsored pension scheme, childcare support, and our flexible “Two Out of Three” benefits concept, which allows employees to receive subsidies for two of the following options: EGYM Wellpass, JobRad, and JobTicket.
NOTICE
*We value diversity and inclusion. Immatics N.V. and all Immatics subsidiaries are equal opportunity employers that evaluate qualified applicants without regard to race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law.
ABOUT IMMATICS
Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics.